BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 22343615)

  • 1. miRNA profiling in colorectal cancer highlights miR-1 involvement in MET-dependent proliferation.
    Reid JF; Sokolova V; Zoni E; Lampis A; Pizzamiglio S; Bertan C; Zanutto S; Perrone F; Camerini T; Gallino G; Verderio P; Leo E; Pilotti S; Gariboldi M; Pierotti MA
    Mol Cancer Res; 2012 Apr; 10(4):504-15. PubMed ID: 22343615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer.
    Kong Y; Bai PS; Sun H; Nan KJ; Chen NZ; Qi XG
    Int J Biochem Cell Biol; 2012 Dec; 44(12):2321-32. PubMed ID: 22903020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met.
    Yan D; Zhou X; Chen X; Hu DN; Dong XD; Wang J; Lu F; Tu L; Qu J
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1559-65. PubMed ID: 19029026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues.
    Bandrés E; Cubedo E; Agirre X; Malumbres R; Zárate R; Ramirez N; Abajo A; Navarro A; Moreno I; Monzó M; García-Foncillas J
    Mol Cancer; 2006 Jul; 5():29. PubMed ID: 16854228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs impair MET-mediated invasive growth.
    Migliore C; Petrelli A; Ghiso E; Corso S; Capparuccia L; Eramo A; Comoglio PM; Giordano S
    Cancer Res; 2008 Dec; 68(24):10128-36. PubMed ID: 19074879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA expression profiles in human colorectal cancers with liver metastases.
    Lin M; Chen W; Huang J; Gao H; Ye Y; Song Z; Shen X
    Oncol Rep; 2011 Mar; 25(3):739-47. PubMed ID: 21174058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-95 promotes cell proliferation and targets sorting Nexin 1 in human colorectal carcinoma.
    Huang Z; Huang S; Wang Q; Liang L; Ni S; Wang L; Sheng W; He X; Du X
    Cancer Res; 2011 Apr; 71(7):2582-9. PubMed ID: 21427358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells.
    Salvi A; Sabelli C; Moncini S; Venturin M; Arici B; Riva P; Portolani N; Giulini SM; De Petro G; Barlati S
    FEBS J; 2009 Jun; 276(11):2966-82. PubMed ID: 19490101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes.
    Schepeler T; Holm A; Halvey P; Nordentoft I; Lamy P; Riising EM; Christensen LL; Thorsen K; Liebler DC; Helin K; Ørntoft TF; Andersen CL
    Oncogene; 2012 May; 31(22):2750-60. PubMed ID: 21963845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-150 as a potential biomarker associated with prognosis and therapeutic outcome in colorectal cancer.
    Ma Y; Zhang P; Wang F; Zhang H; Yang J; Peng J; Liu W; Qin H
    Gut; 2012 Oct; 61(10):1447-53. PubMed ID: 22052060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-1 downregulation cooperates with MACC1 in promoting MET overexpression in human colon cancer.
    Migliore C; Martin V; Leoni VP; Restivo A; Atzori L; Petrelli A; Isella C; Zorcolo L; Sarotto I; Casula G; Comoglio PM; Columbano A; Giordano S
    Clin Cancer Res; 2012 Feb; 18(3):737-47. PubMed ID: 22179665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-185 targets RhoA and Cdc42 expression and inhibits the proliferation potential of human colorectal cells.
    Liu M; Lang N; Chen X; Tang Q; Liu S; Huang J; Zheng Y; Bi F
    Cancer Lett; 2011 Feb; 301(2):151-60. PubMed ID: 21186079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells.
    Bandres E; Bitarte N; Arias F; Agorreta J; Fortes P; Agirre X; Zarate R; Diaz-Gonzalez JA; Ramirez N; Sola JJ; Jimenez P; Rodriguez J; Garcia-Foncillas J
    Clin Cancer Res; 2009 Apr; 15(7):2281-90. PubMed ID: 19318487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c-Met.
    Wu ZS; Wu Q; Wang CQ; Wang XN; Huang J; Zhao JJ; Mao SS; Zhang GH; Xu XC; Zhang N
    Cancer; 2011 Jul; 117(13):2842-52. PubMed ID: 21692045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer.
    Kozaki K; Imoto I; Mogi S; Omura K; Inazawa J
    Cancer Res; 2008 Apr; 68(7):2094-105. PubMed ID: 18381414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development.
    Zhang S; Hao J; Xie F; Hu X; Liu C; Tong J; Zhou J; Wu J; Shao C
    Carcinogenesis; 2011 Aug; 32(8):1183-9. PubMed ID: 21665894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-330 regulates the proliferation of colorectal cancer cells by targeting Cdc42.
    Li Y; Zhu X; Xu W; Wang D; Yan J
    Biochem Biophys Res Commun; 2013 Feb; 431(3):560-5. PubMed ID: 23337504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells.
    Takakura S; Mitsutake N; Nakashima M; Namba H; Saenko VA; Rogounovitch TI; Nakazawa Y; Hayashi T; Ohtsuru A; Yamashita S
    Cancer Sci; 2008 Jun; 99(6):1147-54. PubMed ID: 18429962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Both inhibition and enhanced expression of miR-31 lead to reduced migration and invasion of pancreatic cancer cells.
    Laurila EM; Sandström S; Rantanen LM; Autio R; Kallioniemi A
    Genes Chromosomes Cancer; 2012 Jun; 51(6):557-68. PubMed ID: 22344632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2.
    Ding L; Xu Y; Zhang W; Deng Y; Si M; Du Y; Yao H; Liu X; Ke Y; Si J; Zhou T
    Cell Res; 2010 Jul; 20(7):784-93. PubMed ID: 20548334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.